Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight iSTAR Medical, Xeltis. The fund has specific favorite in a number of founders of portfolio startups.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the LSP, startups are often financed by VI Partners AG, Life Sciences Partners, Kurma Partners. The meaningful sponsors for the fund in investment in the same round are SFPI-FPIM, S.R.I.W., Gimv.
The top activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 deals per year.
|40M||16 Jun 2020||Belgium, " Belgium"}|
|12M||06 Sep 2019||Switzerland, Zurich|
|40M||05 Sep 2019||Belgium, " Belgium"}|
– T-knife Therapeutics, Inc. from Berlin, Germany develops T-cell receptor (TCR) therapeutics for solid tumor patients. – Company completed a $110m Series B financing. – The round was led by Fidelity Management & Research Company, LLC., with participation from other new investors including LSP, Qatar Investment Authority (QIA), Casdin Capital, Sixty Degree Capital, and CaaS Capital, along with existing investors RA Capital Management, Versant Ventures and founding investor Andera Partners. – The new i... Read more
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.